IGeneX Overview
- Year Founded
-
1991

- Status
-
Private
- Employees
-
50

- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
IGeneX General Information
Description
Provider of laboratory and research services intended for private physicians, hospitals and other clinical laboratories. The company's services include laboratory research and testing in a comprehensive way to test relevant strains of tick-borne pathogens including those pathogens and different treatment paths, thereby enabling patients to make a timely diagnosis for starting the right treatment.
Contact Information
Website
www.igenex.comCorporate Office
- 556 Gibraltar Drive
- Milpitas, CA 95035
- United States
Corporate Office
- 556 Gibraltar Drive
- Milpitas, CA 95035
- United States
IGeneX Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
IGeneX Comparisons
Industry
Financing
Details
IGeneX Competitors (6)
One of IGeneX’s 6 competitors is ARUP Laboratories, a Corporation company based in Salt Lake City, UT.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
Genova Diagnostics | Private Equity-Backed | Asheville, NC | ||||
Genoma Group | Corporate Backed or Acquired | Rome, Italy | ||||
NeoGenomics Laboratories | Corporation | Fort Myers, FL | ||||
Igenomix | Formerly PE-Backed | Miami, FL |
IGeneX Patents
IGeneX Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2003265467-A8 | Assay for detection of antigen in bodily fluid | Inactive | 16-Aug-2002 | ||
AU-2003265467-A1 | Assay for detection of antigen in bodily fluid | Inactive | 16-Aug-2002 | ||
US-20040033623-A1 | Using the presence of borellia proteins in urine, cerebral spinal and/or synovial fluids to diagnose lyme disease | Inactive | 16-Aug-2002 | ||
AU-4001199-A | Improved methods for detecting a target nucleic acid fragment | Inactive | 21-May-1998 | ||
CA-2332510-C | In situ hybridization method for detecting target nucleic acid | Inactive | 18-May-1998 | C12Q1/6841 |
IGeneX Signals
IGeneX Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
IGeneX FAQs
-
When was IGeneX founded?
IGeneX was founded in 1991.
-
Where is IGeneX headquartered?
IGeneX is headquartered in Milpitas, CA.
-
What is the size of IGeneX?
IGeneX has 50 total employees.
-
What industry is IGeneX in?
IGeneX’s primary industry is Laboratory Services (Healthcare).
-
Is IGeneX a private or public company?
IGeneX is a Private company.
-
What is IGeneX’s current revenue?
The current revenue for IGeneX is
. -
Who are IGeneX’s investors?
4C Capital and Promise Holdings have invested in IGeneX.
-
Who are IGeneX’s competitors?
ARUP Laboratories, Genova Diagnostics, Genoma Group, NeoGenomics Laboratories, and Igenomix are some of the 6 competitors of IGeneX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »